Over the last decade, transcatheter aortic valve implantation (TAVI) has gained widespread acceptance for the treatment of high surgical risk or inoperable patients with severe aortic stenosis. Spurred on by initial success a
NEW ISSUE
Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…
January 20, 2021